chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lip swelling, lasted approx. 12 hrs, took Benedryl and Pepcid as treatment,. Next morning better.
Onset of chills and low-grade fever approximately 12 hours after the vaccination, waking patient from sleep. Low-grade fever persisted for approximately 16 hours. General malaise the entire day after the vaccination. Vomiting occurred approximately 30 hours after receiving the vaccination.
6month old administered rotovirus live vaccine, without realizing they had not received the first dose. PCP notified, parents notified, documented in chart. Health Dept notified.
Pt was fully covid vaccinated and was hospitalized.   H&P           Age: 71 Years     Sex: Male    Chief Complaint   low HBG 6.5 from facility this AM. Did complete dialysis this AM. HX Left foot external fix. No complaints per pt.  Reason for Consultation  Diabetic Ulcer with External Fixation in place, Left  History of Present Illness     Pt. is a 71-year-old male with PMH DMII, hypertension, hyperlipidemia, diastolic CHF, CAD, hypothyroidism, BPH, COPD maintained on 2 L nasal cannula continuous, anemia atrial fibrillation who was discharged on 12/13/2021 after hospitalization for osteomyelitis of the left foot status post partial calcanectomy of the left foot 11/18/2021 with external fixator placement, presents to the emergency room on 01/07/2022 from rehab center due to hemoglobin 6.5.  Patient has ESRD and is maintained on HD Monday Wednesday Friday.  Patient completed dialysis on 01/07/2022 and then was brought to the emergency room due to hemoglobin 6.5 on outpatient studies.  He reports generalized fatigue but denies any chest pain, palpitations, shortness of breath, cough, syncope. He denies any hematochezia, melena, hematuria or other blood loss.Podiatry was consulted on hospital day on hospital day 5 for wound care management.  Pt. is well known to the Podiatry service and was recently seen by us at center last week.   Unknown manufacturer, date, location vaccine received.
Patient reports a number of dermatologic conditions following about a week after his vaccination - rash down unilateral arm, spread across back, side of torso and chest. Rash characterized by swelling, redness, and itchiness. After 48 - 72 hours rash dries and flakes off, only to reappear later. Arms showed blistering and swelling at the joints, which the patient characterized as "like poison ivy."
Patient came in on 6/24/2022 at 2:45 p.m. to receive her 1st booster of moderna vaccine. Patient should have received a partial dose of 0.25 mg but instead patient received full dose of 0.5 mg. After discovery of wrong dose, patient was quickly notified at 4:50 p.m. At that time patient was feeling extreme fatigue. When I came in Monday,  I called to recheck on patient to see how she was doing and patient stated that this was the worst she had ever felt. She had extreme fatigue and weakness, arm was extremely swollen, red, and painful, ran high temp and sent her into panic attacks. Stated she didn't feel like this with the other 2 times but this one had her feeling rough all weekend. She did state that most symptoms had subsided but her arm was still red and warm and swollen. Made her aware she should probably get that seen just to make sure no infection. Patient voiced understanding.
Woke up feeling very nauseated. Took a Zofran. While standing to get medication from cabinet my vision went completely black and face cold and clammy. I slowly laid down with feet above heart until it subsided and slowly went back to bed. My galaxy watch says pulse dropped to 40. Normally 60's. Later in the morning at 7am chills started and migraine with light aura (kind of like the pixels on an old tv). Took asa, tylenol, and drank water to help. Feeling hazy all day.
I tested positive on the 30th. I started feeling sniffily on Saturday and took a test that was negative. I felt achy, had chills, and felt warm. I felt a bit better Sunday but started getting congested and had muscles aches. I did have a temperature of 101 degrees. I had some back discomfort and chills. I retested Monday morning and tested positive. I tried to get Paxlovid from my doctor, but they required me to come in. They tested me again for COVID-19, strep and the flu on February 1. I also lost my taste and smell, this symptom lasted longer than anything else.
hard to touch; arm is swollen red itchy; internal itching; arm is swollen red itchy,; bumps on back; arm is swollen red itchy,; bumps on back; body started itching; swelling spread and on arm; under arm was extremely painful; body started itching; arm was sore; light headed; Dizzy; extremely hot sweat running down her face; pins and needles feeling; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed), DIZZINESS (Dizzy), HYPERHIDROSIS (extremely hot sweat running down her face), PARAESTHESIA (pins and needles feeling) and the first episode of PRURITUS (body started itching) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included norethindrone acetate.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (light headed), DIZZINESS (Dizzy), HYPERHIDROSIS (extremely hot sweat running down her face) and PARAESTHESIA (pins and needles feeling). On 06-Apr-2021, the patient experienced MYALGIA (arm was sore). On 09-Apr-2021, the patient experienced the first episode of PRURITUS (body started itching). On 10-Apr-2021, the patient experienced AXILLARY PAIN (under arm was extremely painful). On 11-Apr-2021, the patient experienced the second episode of PRURITUS (body started itching) and PERIPHERAL SWELLING (swelling spread and on arm). On 14-Apr-2021, the patient experienced CONTUSION (bumps on back). On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen red itchy), PRURITUS (internal itching), PRURITUS (arm is swollen red itchy,), SWELLING (bumps on back) and ERYTHEMA (arm is swollen red itchy,). On an unknown date, the patient experienced INDURATION (hard to touch). On 12-Apr-2021, AXILLARY PAIN (under arm was extremely painful) had resolved. At the time of the report, DIZZINESS (light headed), DIZZINESS (Dizzy), HYPERHIDROSIS (extremely hot sweat running down her face), PARAESTHESIA (pins and needles feeling), the last episode of PRURITUS (body started itching), PERIPHERAL SWELLING (swelling spread and on arm), INDURATION (hard to touch), CONTUSION (bumps on back), PERIPHERAL SWELLING (arm is swollen red itchy), PRURITUS (internal itching), PRURITUS (arm is swollen red itchy,), SWELLING (bumps on back), MYALGIA (arm was sore) and ERYTHEMA (arm is swollen red itchy,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicine included acetaminophen for sore arm, diphenhydramine for "body started itching, swelling spread and on arm" and ice pack for "bumps" and ice pack for hard to touch
Very strong flu like symptoms, aching all over body as if you had a bad case of flue. Worst by 7:00 pm. Took ibprophin and went to bed. OK next morning  about 10 hours later. Also red blotch on both sides of body from belt line to arm pit.
PT with 3-5 mm annular macular along trunk and both arms. Macular blanch and one pruritic. Maculi with some fine scale. No pustules seen, no fluid or exudati seen.
Adult pt received the pediatric dose of HepA (0.5cc) vaccine, instead of the the adult dose (1.0cc) of HepA vaccine. Therefore, the pt does not gain the full, lifetime protection from this vaccine.
Stomach pain; Diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the patient had her first shot on 05Mar2021 and was due to get her second dose tomorrow. She mentioned that she currently had stomach pain and diarrhea. The patient would like to know if it is okay for her to take the second dose. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
vaccine expired on 29Apr2022 and stored in the refrigerator the same date that the dose was administered; expired doses administered to patient; The patient received his first dose of Moderna on 01Jan2021, second Moderna dose on 07Feb2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first dose of Moderna on 01Jan2021, second Moderna dose on 07Feb2021), EXPIRED PRODUCT ADMINISTERED (expired doses administered to patient) and PRODUCT STORAGE ERROR (vaccine expired on 29Apr2022 and stored in the refrigerator the same date that the dose was administered) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 07-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first dose of Moderna on 01Jan2021, second Moderna dose on 07Feb2021). On 17-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine expired on 29Apr2022 and stored in the refrigerator the same date that the dose was administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first dose of Moderna on 01Jan2021, second Moderna dose on 07Feb2021), EXPIRED PRODUCT ADMINISTERED (expired doses administered to patient) and PRODUCT STORAGE ERROR (vaccine expired on 29Apr2022 and stored in the refrigerator the same date that the dose was administered) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. It was reported that vial was initially stored in the refrigerator on the same day of administration. It was reported that the vial did not undergo temperature excursion. The Lot 042J21A expired on 29-Apr-2022. Treatment information was not provided.
I first noticed a small dot of inflammation around 10:00 P.M last night 2/4/21. T his morning the area surrounding  the injection site is  hot and red. The inflamed area measures about 3x4inches, There is no pain or itchiness associated. I have been icing the area.
Patient not received the 2nd dose.; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (on 4th November 2022 received 1st dose).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Patient not received the 2nd dose.). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 09-AUG-2023 The patient self-reported this case. The patient reported that he got the first shot at a pharmacy that was referred by his doctor. The patient asked about insurance coverage and locations where Shingrix was administered. One organization advised them, they could only go to his doctor to get the second shot. Not to a pharmacy. Per policy.  They paid for first shot because they advised the patient wrong the first time, according to them.  The patient stated that his doctor did not carry the shot, so he had not gotten the second shot as of this date and the organization stated the patient could not go to a pharmacy to get the shot.  Today their doctor handed them a coupon/advertisement to go to their local pharmacy.  The reporter did not think this was going to work. The reporter wanted to know what he should do. Till the time of reporting the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
Fainted for about 10 sec., looking yellowish. Gave her alcohol to breathe. Water and juice were provided. *Pt had not eaten anything before vaccinated.
SWELLING, HURTING ARM, AND PT COMPLAINED OF TINGLING FEELING IN LEG.  PT COULDN'T STAND LONG AND COULDN'T MOVE ARM.
Vital signs stable. Pt had large erythematous rash that extended down his post. aspect of right arm, 24 hours after vaccination.  Area was warm to the touch.  Another area of eyrthema was noted on medial aspect of same arm that was also edematous and warm.  Both areas had blanching erythema and was not tender.  Pt reported purrtis.  Pt denied any airway problems.  Pt treated with antihistamines and instructed to follow up in 1 week.
Extreme fatigue; sore arm at injection site; itchy arm; body soreness; irregular periods (three in six weeks); lump under arm-near breast of arm that received injection
Injection area of right deltoid with a 13cm area with edema, induration and warm to the touch.
COVID 19 Treatment; COVID 19 Treatment; vaccine brand=Pfizer/BioNTech/Vaccine brand other=Moderna; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Sep2022 as dose 4 (booster), single (Lot number: GH9694) and on 01Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 42 years for covid-19 immunisation; bnt162b2 (BNT162B2), on 14Apr2021 as dose 1, single (Lot number: EW0164) and on 05May2021 as dose 2, single (Lot number: EW0165) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 11Nov2021 as dose 3 (booster), single (Lot number: 037C21A) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism (mild)" (ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 01Nov2022, outcome "unknown", described as "vaccine brand=Pfizer/BioNTech/Vaccine brand other=Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative, notes: after testing negative twice; Negative, notes: after testing negative twice. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: COVID 19 Treatment was given with Paxlovid from 16Oct2023 to 20Oct2023. No Known allergies  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Covid 19 positive 08/25/21 with onset of symptoms 08/26/2021
pt started having itching & heaviness lt arm 11APR98 PM;16APR98 to clinic 330PM BP 170/100, T96,6, P72 resp easy;reports intense itching lt arm;induration irregular shape cover 2/3 circumference;erythema blotches w/in induration;tender;
Headache, muscle aches, muscle pain, join pain, fatigue, fever (has since broken). Nausea (since gone away), injection site pain.  Cough
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 41 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 01Nov2021 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "high cholesterol" (unspecified if ongoing); "Former smoker" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing); "Interchange of vaccine product" (unspecified if ongoing). Concomitant medication(s) included: PITAVASTATIN CALCIUM, start date: 01Oct2021, stop date: 07Jul2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (02Jul2022) Negative, notes: Tested negative on 02Jul2022; (05Jul2022) Positive, notes: Tested positive again on 05Jul2022. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient took Anti-viral drug Paxlovid from 26Jun2022 to 30Jun2022 for COVID 19 Treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
June 2021 my thighs hurt & eventually couldn?t walk without help,. June 21, 2022 legs still weak. I fractured knee because legs couldn?t hold me up. I?ve had UTIS every 2 months starting August 2021. Passing out, EMS called & been admitted 3-4 times.
This spontaneous report was received from a registered nurse and refers to 4-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 16-MAY-2017, the patient was vaccinated with improperly stored dose of PROQUAD lot # L046506, expiration date of 17-MAY-2017 (dose and route of administration were not reported). The vaccine was reconstituted with properly stored sterile diluent (DILUENT MRK). Administered dose of vaccine experienced the temperature excursion between 6 degrees Fahrenheit (°F) and 14 °F for 30 minutes. The reported also stated that two separate temperature excursions took place: the first on 03-FEB-2017 and the second on 18-APR-2017 and that the vaccine was deemed to still be viable. No previous temperature excursion occurred. No product quality complaint was involved. No adverse effects were reported. Data logger was involved. This is one of several reports received from the same source.  Additional information is not expected as all relevant information has already been received.; Sender's Comments: US-009507513-1704USA009837: US-009507513-1704USA010916: US-009507513-1706USA003474: US-009507513-1706USA003475: US-009507513-1706USA003476: US-009507513-1706USA003477: US-009507513-1706USA003478: US-009507513-1706USA003479: US-009507513-1706USA003480: US-009507513-1706USA003481: US-009507513-1706USA003482: US-009507513-1706USA003483: US-009507513-1706USA003484: US-009507513-1706USA003485: US-009507513-1706USA003486: US-009507513-1706USA003487: US-009507513-1706USA003489:
pt recvd vax; approx 1 hr later, started shaking,felt cold,mottled appearing; t102.9; pulse ox 71%; to er CXR 21oct; RML infiltrate not present 10/19;
started feeling sick; Coughing; Flu like symptoms; aching; Fever; Headache; Freezing; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started feeling sick), COUGH (Coughing), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (aching) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HCL, OMEPRAZOLE, CLOPIDOGREL, METOPROLOL and SIMVASTATIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MALAISE (started feeling sick), COUGH (Coughing), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (aching), PYREXIA (Fever), HEADACHE (Headache), FEELING COLD (Freezing) and CHILLS (chills). At the time of the report, MALAISE (started feeling sick), COUGH (Coughing), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (aching), HEADACHE (Headache), FEELING COLD (Freezing) and CHILLS (chills) outcome was unknown and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 23-Feb-2021, the patient tested negative for covid-19. Treatment information included dextromethorphan (16 mg), guaifenesin 1200 mg 2/day, and at the time of the report she was still taking ibuprofen and paracetamol.
Patient was given Proquad in left upper arm subq.  Started immediately with redness and swelling that has progressed. Seen for advisement. She prescribed antibiotic.
Information has been received from a 26 year old female with no medical history or allergies who in 1995 was vaccinated SC with a first 0.5 ml dose of varicella virus vaccine live (Oka/Merck) and on 28-SEP-2007 the patient received second SC 0.5 ml dose of vaccine. Concomitant therapy included fexofenadine hydrochloride (ALLEGRA) and vitamins. It was reported that "recently" the patient had low antibody titers. On 29-SEP-2007 the patient developed redness, tenderness and swelling at injection site. The area of swelling increased in size on 30-SEP-2007 but had subsequently improved. The patient called her physician on 01-OCT-2007 and was going to see the physician on 02-OCT-2007. At the time of report the patient was recovering. No diagnostic laboratory tests were undertaken. A product quality complaint was not involved. Additional information is not expected/
Yellow fever vaccines (Yf-Vax) was administered subcutaneously on the Deltoid instead of behind arm where fatty tissue was located . Patient was contacted and she did not experienced any adverse reaction. Manufacture was contacted and was told the effectiveness was not affected
Chest pain, difficulty breathing; tx admission, IV D50, solumedrol, alburetal to CCU;
The patient received COVID19 Pfizer-BioNTech vaccine at 4 weeks' gestation. During prenatal anatomical scan on 6/13/21 , baby diagnosed with one swollen kidney (hydronephrosis) which was confirmed upon birth.
5 inch raised red, itchy, hot to touch, sore, mark at injection site on left arm.